05.00.86, Remote Electrical Neuromodulation for Migraines
Summary
Independence Blue Cross has reissued policy 05.00.86 with NO CHANGES to the existing coverage criteria for remote electrical neuromodulation (REN) devices like Nerivio for migraine prevention. The policy status remains MEDICALLY NECESSARY for qualifying adults (18+) and pediatric patients (8-17) who meet specific clinical criteria. This is an administrative reissuance for annual review purposes with an effective date of January 1, 2026.
Get alerts when payers change rules like this one
We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.